Print ISSN:-2394-2789
Online ISSN:-2394-2797
CODEN : IJPCN9
Original Article
Author Details :
Volume : 11, Issue : 2, Year : 2024
Article Page : 175-179
https://doi.org/10.18231/j.ijpca.2024.025
Abstract
The purpose of this study is to establish Zero-order UV-Spectrophotometric - absorbance and Zero Order- Area under curve (AUC) methods for estimation of Fenticonazole Nitrate in bulk and vaginal capsules. Fenticonazole Nitrate is an antifungal drug and it is completely insoluble in water. Methanol was used as solvent for solubilization of Fenticonazole Nitrate. Maximum absorption for Fenticonazole Nitrate was found to be at wavelength 253 nm when dissolved in Methanol. The methods are based upon measurement of absorbance at 253nm and integration of area under curve for analysis of Fenticonazole Nitrate in the wavelength range of 242-262 nm. The drug followed linearity in the concentration range of 5 - 30µg/mL with correlation coefficient value r> 0.99 for both methods. The proposed methods were validated for accuracy (% recovery), precision, repeatability and ruggedness, as per ICH guidelines. The proposed methods were applied for qualitative and quantitative estimation of Fenticonazole Nitrate in vaginal capsules and results were found in good agreement with the label claimed. Developed methods can be used for routine analysis of Fenticonazole Nitrate in bulk and Vaginal Capsules.
Keywords: Fenticonazole Nitrate, Methanol, UV Spectrophotometry, AUC Spectrophotometry Vaginal Capsules
How to cite : Gorle A, Jain P, Nerkar P, Haswani N, Chordiya S, Kommakayam S H, Quantitative estimation of fenticonazole nitrate by zero-order derivative area under curve spectrophotometric methods in bulk and in-capsule dosage form. Int J Pharm Chem Anal 2024;11(2):175-179
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.